Cordis Corp., Johnson & Johnson's stenting arm, notched another 510(k) clearance for its Adroit 6F Guiding Catheter, which the company says can handle more sophisticated lesions.

Cordis Corp., the stent-making division of Johnson & Johnson, landed a new U.S. regulatory win for its next-generation Adroit 6F Guiding Catheter, which the company said can handle more sophisticated cases than earlier versions.

The company is calling the Adroit 6F an "innovative hybrid braid wire" device that makes it easier for doctors to treat complex lesions and use the radial approach to catheterization.

Source: Cordis Corp.